7.01 (-%)
As of Nov 22, 2024
Source:
Silence Therapeutics Plc is a biotechnology company focused on discovering and developing novel molecules incorporating short interfering ribonucleic acid, or siRNA, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need.
| Country | United Kingdom |
| Headquarters | london |
| Phone Number | 44-0-20-3457 6900 |
| Industry | manufacturing |
| CEO | Craig Tooman |
| Website | www.silence-therapeutics.com. |